Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is associated with malignant transformation
about
Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survivalOverexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liverDifferential growth factor regulation of aspartyl-(asparaginyl)-beta-hydroxylase family genes in SH-Sy5y human neuroblastoma cells.Upstream stimulatory factors are involved in the P1 promoter directed transcription of the A beta H-J-J locusDevelopment of a novel anti-human aspartyl-(asparaginyl) β-hydroxylase monoclonal antibody with diagnostic and therapeutic potential.Identification of a novel tumor transforming gene GAEC1 at 7q22 which encodes a nuclear protein and is frequently amplified and overexpressed in esophageal squamous cell carcinoma.Motor Function Deficits Following Chronic Prenatal Ethanol Exposure are Linked to Impairments in Insulin/IGF, Notch and Wnt Signaling in the Cerebellum.Prognostic value of aspartyl (asparaginyl)-beta-hydroxylase/humbug expression in non-small cell lung carcinomaA cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinomaAspartyl-(asparaginyl) beta-hydroxylase, hypoxia-inducible factor-alpha and Notch cross-talk in regulating neuronal motilityAspartate β-Hydroxylase expression promotes a malignant pancreatic cellular phenotypeImmunization with aspartate-β-hydroxylase-loaded dendritic cells produces antitumor effects in a rat model of intrahepatic cholangiocarcinoma.Precision-cut slice culture method for rat placenta.Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma.Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression.Ceramide inhibitor myriocin restores insulin/insulin growth factor signaling for liver remodeling in experimental alcohol-related steatohepatitis.Potential Role of Phosphorylation as a Regulator of Aspartyl-(asparaginyl)-β-hydroxylase: Relevance to Infiltrative Spread of Human Hepatocellular Carcinoma.Optimized Expression and Purification of Humbug in Pichia pastoris and Its Monoclonal Antibody Preparation.Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma.siRNA inhibition of aspartyl-asparaginyl β-hydroxylase expression impairs cell motility, Notch signaling, and fetal growth.Impaired placentation in fetal alcohol syndrome.Aspartate-β-hydroxylase (ASPH): A potential therapeutic target in human malignant gliomas.Role of Notch signaling pathway in pancreatic cancer.A Radiolabeled Fully Human Antibody to Human Aspartyl (Asparaginyl) β-Hydroxylase Is a Promising Agent for Imaging and Therapy of Metastatic Breast Cancer.Potential Co-Factor Role of Tobacco Specific Nitrosamine Exposures in the Pathogenesis of Fetal Alcohol Spectrum DisorderLambda phage-based vaccine induces antitumor immunity in hepatocellular carcinoma.Tobacco Nitrosamine Exposures Contribute to Fetal Alcohol Spectrum Disorder Associated Cerebellar Dysgenesis.Ethanol-Induced White Matter Atrophy Is Associated with Impaired Expression of Aspartyl-Asparaginyl-β-Hydroxylase (ASPH) and Notch Signaling in an Experimental Rat Model.Phosphorylation Modulates Aspartyl-(Asparaginyl)-β Hydroxylase Protein Expression, Catalytic Activity and Migration in Human Immature Neuronal Cerebellar Cells.Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition Pathway.Biomarkers for the Diagnosis of Cholangiocarcinoma: A Systematic ReviewAspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation
P2860
Q24655625-9524A777-B95D-45A4-8396-EEA990BC2BE3Q28246572-24C55709-7621-4A92-942E-19F51EDDF3E7Q33265938-1BE0BEB3-5DC4-4808-AE06-A9FF1BD826C7Q33393444-32E51441-42A0-4017-A999-2C8A35521C0EQ33599455-DCB122E3-6D77-4938-90F9-89CA1536CC33Q33874594-D20BFFC0-68C0-4282-AE46-0BE7B6BF6653Q33897454-FFC21F60-4D08-4436-8A21-B1A0E6C22E00Q33944587-2CB3E93B-B8A9-4DE6-868E-A55CCEF56FFAQ34250364-8102CD9C-8BF5-461B-8212-7E651A2AD2DAQ35157948-C7D8049A-2071-4D89-A064-BDE319B6BB45Q35176052-D7F99FC8-751F-4378-BFF5-2442E58D78BCQ35624314-B8AF2242-AFA6-43B5-8D20-E8130F14A56CQ35643230-09A399B2-C3E1-4D6A-B220-85F6448B77FBQ35894880-98617768-2686-4F81-8607-2E07EBFD8749Q35949450-53F22501-1BBD-4276-BE55-50F579CE10C6Q36001362-0761E580-1CD1-4150-9BA2-BB75ABE07A95Q36170624-F6F81597-4397-4540-8D00-6CBACEB36761Q36495723-CC93121D-5778-4B33-BCD7-BE22CB9CD90CQ36723189-BC5EBB79-DFBD-418E-9822-99094C98A5E7Q37023897-AF1F7944-C796-473D-BE5D-CF44C8CFF45DQ37216866-0211DD6E-1357-4CA4-BFCD-B8CC7A4B5701Q37485171-6BF5A3E5-CB12-4429-94CA-7C6967796CAEQ37679979-09F0C4BD-EE22-40FE-99D1-2AC2A2EA8197Q38712008-BFE048AB-E853-40DA-94DE-180DBB7215EAQ41513131-4EB1352A-544D-4E44-9055-FEB0402CBB4CQ42366399-1A682674-2767-4BE9-BC57-8530A4DC7E46Q47127142-353AB1AC-4747-4F1D-8164-BEBB5663A368Q47331366-D66C83EE-4DA5-4B8F-9B7F-7C88145E4104Q53092252-B2D0289A-3B7C-47B8-B84E-50EEA1B7524DQ55378664-3CA3CC83-7154-44F8-8623-C7A982C3A8A7Q56379222-1A16A440-627D-43CB-B383-55C3B5008C21Q57112122-D054D1E7-C56C-4E28-B08F-5A1D4403DFB3
P2860
Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is associated with malignant transformation
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Overexpression of human aspart ...... with malignant transformation
@ast
Overexpression of human aspart ...... with malignant transformation
@en
Overexpression of human aspart ...... with malignant transformation
@nl
type
label
Overexpression of human aspart ...... with malignant transformation
@ast
Overexpression of human aspart ...... with malignant transformation
@en
Overexpression of human aspart ...... with malignant transformation
@nl
prefLabel
Overexpression of human aspart ...... with malignant transformation
@ast
Overexpression of human aspart ...... with malignant transformation
@en
Overexpression of human aspart ...... with malignant transformation
@nl
P2093
P1433
P1476
Overexpression of human aspart ...... with malignant transformation
@en
P2093
S M de la Monte
P304
P407
P577
2000-03-01T00:00:00Z